These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The adrenal medulla and Parkinson's disease. Stoddard SL Rev Neurosci; 1994; 5(4):293-307. PubMed ID: 7697198 [TBL] [Abstract][Full Text] [Related]
7. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites. Miano L; Kolloch R; De Quattro V Clin Chim Acta; 1979 Jul; 95(2):211-7. PubMed ID: 527220 [TBL] [Abstract][Full Text] [Related]
8. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. Greenspan K; Schildkraut JJ; Gordon EK; Levy B; Durell J Arch Gen Psychiatry; 1969 Dec; 21(6):710-6. PubMed ID: 4901154 [No Abstract] [Full Text] [Related]
9. Mania: sympathoadrenal function and clinical state. Swann AC; Secunda SK; Koslow SH; Katz MM; Bowden CL; Maas JW; Davis JM; Robins E Psychiatry Res; 1991 May; 37(2):195-205. PubMed ID: 1876629 [TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Six-hour infusion of epinephrine and norepinephrine in healthy volunteers. Moleman P; Tulen JH; Blankestijn PJ; Man in 't Veld AJ; Boomsma F Arch Gen Psychiatry; 1992 Jul; 49(7):568-72. PubMed ID: 1627048 [TBL] [Abstract][Full Text] [Related]
11. The urinary excretion of catecholamines and their derivatives in primary hypertension in man. Bing RF; Harlow J; Smith AJ; Townshend MM Clin Sci Mol Med; 1977 Mar; 52(3):319-23. PubMed ID: 557404 [TBL] [Abstract][Full Text] [Related]
12. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans. Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832 [TBL] [Abstract][Full Text] [Related]
13. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography-tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis. Woo HI; Yang JS; Oh HJ; Cho YY; Kim JH; Park HD; Lee SY Clin Biochem; 2016 May; 49(7-8):573-9. PubMed ID: 26779993 [TBL] [Abstract][Full Text] [Related]
14. Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease. Tyce GM; Ahlskog JE; Carmichael SW; Chritton SL; Stoddard SL; van Heerden JA; Yaksh TL; Kelly PJ J Lab Clin Med; 1989 Aug; 114(2):185-92. PubMed ID: 2754305 [TBL] [Abstract][Full Text] [Related]
15. Positive correlation between urinary excretion of catecholamine metabolites and tumour mass in pheochromocytoma. Results in patients with sustained and paroxysmal hypertension and multiple endocrine neoplasia. Stenström G; Waldenström J Acta Med Scand; 1985; 217(1):73-7. PubMed ID: 3976435 [TBL] [Abstract][Full Text] [Related]
16. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine. Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873 [TBL] [Abstract][Full Text] [Related]
17. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. Bravo EL; Tarazi RC; Gifford RW; Stewart BH N Engl J Med; 1979 Sep; 301(13):682-6. PubMed ID: 481462 [TBL] [Abstract][Full Text] [Related]
18. Age-related changes in catecholamine metabolites of human urine from birth to adulthood. Dalmaz Y; Peyrin L; Sann L; Dutruge J J Neural Transm; 1979; 46(2):153-74. PubMed ID: 512651 [TBL] [Abstract][Full Text] [Related]